-
Mashup Score: 96Genentech: Press Releases | Sunday, Apr 14, 2024 - 14 day(s) ago
Discover the latest news about our company, our products, our policies, and our people.
Source: www.gene.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 32Genentech: Press Releases | Thursday, Apr 18, 2024 - 19 day(s) ago
Discover the latest news about our company, our products, our policies, and our people.
Source: www.gene.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 32Genentech: Press Releases | Thursday, Apr 18, 2024 - 19 day(s) ago
Discover the latest news about our company, our products, our policies, and our people.
Source: www.gene.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 32Genentech: Press Releases | Thursday, Apr 18, 2024 - 19 day(s) ago
Discover the latest news about our company, our products, our policies, and our people.
Source: www.gene.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 77Genentech: Press Releases | Sunday, Apr 14, 2024 - 23 day(s) ago
Discover the latest news about our company, our products, our policies, and our people.
Source: www.gene.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 26Genentech: Press Releases | Sunday, Feb 25, 2024 - 2 month(s) ago
Discover the latest news about our company, our products, our policies, and our people.
Source: www.gene.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 69Genentech: Press Releases | Friday, Feb 16, 2024 - 3 month(s) ago
Discover the latest news about our company, our products, our policies, and our people.
Source: www.gene.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 0Genentech: Press Releases | Wednesday, Jan 31, 2024 - 3 month(s) ago
Discover the latest news about our company, our products, our policies, and our people.
Source: www.gene.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 14Genentech: Press Releases | Tuesday, Dec 19, 2023 - 5 month(s) ago
Discover the latest news about our company, our products, our policies, and our people.
Source: www.gene.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 6Genentech: Press Releases | Sunday, Dec 10, 2023 - 5 month(s) ago
Discover the latest news about our company, our products, our policies, and our people.
Source: www.gene.comCategories: General Medicine News, PayerTweet
Press release: Overall Survival advantage for R-GemOx + glofitamab versus R-GemOx in relapsed DLBCL in patients not fit for autologous transplant. The STARGLO study. Good to see a DLBCL study with OS as the primary EP. Keen to see the data! #lymsm https://t.co/A6TZ7p2Nxu.